MIT Biotech Group retweeted
Join us at the @MITBiotechGroup Career Fair! Representing us will be our cryoEM expert and former @MIT faculty, a member of our Protein Engineering team and MIT alumna, and a member of our talent acquisition team. Learn about the positions we’re offering: generatebiomedicines.com/car…
MIT Biotech Group retweeted
Last week, our SVP of Corporate Strategy and Development Jonathan Gilbert returned to his alma mater, @MIT, to share his experiences as an accomplished #biotech executive with the @MITBiotechGroup.
Jon had a wonderful time connecting with the next generation of industry leaders.
MIT Biotech Group retweeted
Join the 2021 @MITBiotechGroup Career Fair on Friday, March 19th, 2021, from 12 - 4 pm! This one-day virtual event provides a platform for companies in the biotech, consulting, and VC space to connect with talent within the @MIT community. Register Now: bit.ly/3kmvLSR
MIT Biotech Group retweeted
High quality teams represented at @mitbiotechgroup and @thebiotechclub ideation 2019, hope to see some of you at Grand Hack #Grandhack2019
MIT Biotech Group retweeted
An amazing talk and dinner with @polsiewski from @SloanFoundation about philanthropy and non-research careers stemming from PhD programs tonight @MIT @MITdeptofBE @MITBiotechGroup
MIT Biotech Group retweeted
Thanks to @Amgen for hosting Joachim Frank, 2017 chemistry nobel prize winner, and @MITBiotechGroup for facilitating extended site tour. Lots of advances being made in Cryo-EM imaging
MIT Biotech Group retweeted
Tomorrow Nimbus’ Jeb Keiper will lead a discussion on fundraising for private biotech companies for Ph.D. students at the MIT Biotech Group. Enjoy being back at your alma mater, Jeb! biotech.mit.edu/2018/03/mbg-…
MIT Biotech Group retweeted
Pumped to speak @MIT to the @MITBiotechGroup this coming Wednesday (4/4). Plan to share the gory detail and data behind biotech financing. biotech.mit.edu/2018/03/mbg-…
MIT Biotech Group retweeted
OX40 agonists have been a real bummer so far in the clinic for IO, but this is a compelling story in HBV immunity
stm.sciencemag.org/content/1…
MIT Biotech Group retweeted
No. If a company wants to buy a block of tickets and give them to students at @MITBiotechGroup or Univ. of Wash, we can talk. But these events are dynamite, and a bargain at $295. Also crucial components of my fundraising strategy for @climbtofight @fredhutch xitter.cf/varma_ashwin97/status/…
MIT Biotech Group retweeted
Could a probiotic reduce the toxicity of #cancer immunotherapy?
An intriguing @StanfordMed experimental study pnas.org/content/early/2017/… @PNASNews
MIT Biotech Group retweeted
I'm making a list of "biocurious" tech investors - as @eperlste puts it
I.e. Tech funds that are funding computational bio/diagnostics (vs. therapeutics) & have dedicated partner(s)
So far: @socialcapital @trueventures @CRV @a16z @gcvp @MenloVentures @khoslaventures
Others?
MIT Biotech Group retweeted
Replying to @EricTopol @NeuroCellPress
MIT Biotech Group retweeted
Deconstructing how your body goes one way when your #brain goes another cell.com/neuron/fulltext/S08… @NeuroCellPress
MIT Biotech Group retweeted
Grad students in biology: I'm working on a column about the tax plan and its effect on you. Speaking w/ @MITBiotechGroup Tell me your stories [email protected]
MIT Biotech Group retweeted
The Microbiome: New Technology, Commercial Challenges and Opportunities. Guest post from @MITBiotechGroup timmermanreport.com/2017/12/…
MIT Biotech Group retweeted
Lots to learn in @Frank_S_David book about biotech finance. @MITBiotechGroup surely will be an avid audience. xitter.cf/bradloncar/status/9182…
If you are in Boston, check out @Frank_S_David's talk/book on financial modeling for biopharma. It's a good one. xitter.cf/julierenal/status/9182…
MIT Biotech Group retweeted
"Story of CAR-T says as much about the methodical nature of scientific progress as about passions that sustain it" nejm.org/doi/full/10.1056/NE…
MIT Biotech Group retweeted
The biomedical research community must maintain its critical role in comprehensive pandemic preparedness ja.ma/2ybdgLX
MIT Biotech Group retweeted
Boston folks: I'm talking about biotech financial models on 10/18 at @MITBiotechGroup - please come! biotech.mit.edu/2017/09/fran…




























